Squamous anal cancer: Patient characteristics and HPV type distribution

Cancer Epidemiology

Volumn 37, Issue 6, 2013, Pages 807-812

  Ouhoummane, N ^a   Steben, M ^a,b   Coutlee F ^c   Vuong, Te ^d   Forest, P ^c   Rodier, C ^e   Louchini, R ^f   Duarte, E ^g   Brassard, P ^b,h  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e Merck Canada Inc   (Canada)

^f Ministère de la Santé et des Services Sociaux du Québec   (Canada)

^g MCGILL UNIVERSITY   (Canada)

^h MCGILL UNIVERSITY   (Canada)

Author keywords

Anal cancer; Epidemiology; HPV type; Human papillomavirus

Indexed keywords

VIRUS DNA;

ADULT; AGED; ANUS CANCER; ARTICLE; CANADA; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; URBAN AREA; VIRUS ISOLATION; VIRUS TYPING;

ANAL CANCER; EPIDEMIOLOGY; HPV TYPE; HUMAN PAPILLOMAVIRUS;

ADENOCARCINOMA; AGED; ANUS NEOPLASMS; CANADA; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84888304623     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.09.015     Document Type: Article

References (42)

1. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M. Cancer incidence in five continents, vol. IX. IARC scientific publications no. 160. Lyon: 2007. Ref Type: Report.
2. Jin F., Stein A.N., Conway E.L., Regan D.G., Law M., Brotherton J., et al. Trends in anal cancer in Australia, 1982-2005. Vaccine 2011, 29:2322-2327.
3. Johnson L.G., Madeleine M.M., Newcomer L.M., Schwartz S.M., Daling J.R. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004, 101:281-288.
4. Louchini R., Goggin P., Steben M. The evolution of HPV-related anogenital cancers reported in Quebec - incidence rates and survival probabilities. Chronic Dis Can 2008, 28:99-106.
5. Nielsen A., Munk C., Kjaer S.K. Trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark, 1978-2008. Int J Cancer 2011.
6. Robinson D., Coupland V., Moller H. An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England. Br J Cancer 2009, 100:527-531.
7. Dubé E, Gilca V, Goggin P, Sauvageau C, Comité sur l'immunisation du Québec et comité scientifique AD HOC VPH. La vaccination contre les VPH au Québec: mise à jour des connaissances et propositions du comité d'experts. Institut national de santé publique du Québec, 2012. Ref Type: Report.
8. Chiao E.Y., Krown S.E., Stier E.A., Schrag D. A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr 2005, 40:451-455.
9. D'Souza G., Wiley D.J., Li X., Chmiel J.S., Margolick J.B., Cranston R.D., et al. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2008, 48:491-499.
10. Diamond C., Taylor T.H., Aboumrad T., Bringman D., Anton-Culver H. Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy. Sex Transm Dis 2005, 32:314-320.
11. Jimenez W., Paszat L., Kupets R., Wilton A., Tinmouth J. Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario. Gynecol Oncol 2009, 114:395-398.
12. Patel H.S., Silver A.R., Northover J.M. Anal cancer in renal transplant patients. Int J Colorectal Dis 2007, 22:1-5.
13. Silverberg M.J., Lau B., Justice A.C., Engels E., Gill M.J., Goedert J.J., et al. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis 2012, 54(7):1026-1034. 10.1093/cid/cir1012.
14. Melbye M., Sprogel P. Aetiological parallel between anal cancer and cervical cancer. Lancet 1991, 338:657-659.
15. Cogliano V., Baan R., Straif K., Grosse Y., Secretan B., El G.F. Carcinogenicity of human papillomaviruses. Lancet Oncol 2005, 6:204.
16. IARC IARC monograph on the evaluation of carcinogenic risks to humans, vol. 90. Human papillomaviruses 2007, International Agency for Research on Cancer, Lyon, France.
17. De Vuyst H., Clifford G.M., Nascimento M.C., Madeleine M.M., Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009, 124:1626-1636.
18. Hoots B.E., Palefsky J.M., Pimenta J.M., Smith J.S. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009, 124:2375-2383.
19. Abramowitz L., Jacquard A.C., Jaroud F., Haesebaert J., Siproudhis L., Pradat P., et al. Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study. Int J Cancer 2011, 129(2):433-439. 10.1002/ijc.25671.
20. Gohy L., Gorska I., Rouleau D., Ghattas G., Pokomandy Ad., Vezina S., et al. Genotyping of human papillomavirus DNA in anal biopsies and anal swabs collected from HIV-seropositive men with anal dysplasia. J Acquir Immune Defic Syndr 2008, 49:32-39.
21. Coutlée F., Rouleau D., Petignat P., GhattasF G., Kornegay J.R., Schlag P., et al. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the linear array HPV genotyping test. J Clin Microbiol 2006, 44:1998-2006.
22. Coutlée F., Rouleau D., Ghattas G., Hankins C., Vézina S., Coté P., et al. Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test. J Clin Microbiol 2007, 45:3821-3823.
23. de Roda Husman A.M., Walboomers J.M., van den Brule A.J., Meijer C.J., Snijders P.J. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995, 76(Pt 4):1057-1062.
24. Jacobs M.V., de Roda Husman A.M., van den Brule A.J., Snijders P.J., Meijer C.J., Walboomers J.M. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995, 33:901-905.
25. Gorska-Flipot I., Sawick J., Gaboury L.A., Krajinovic M., Labuda D., Brukner I., et al. Newly-isolated HPV97, related to HPV18 and 45 is frequently detected in HIV-positive men from the Montreal area. Int J Cancer 2008, 122:1195-1197.
26. Alotaibi L., Provost N., Gagnon S., Franco E.L., Coutlee F. Diversity of cutaneous human papillomavirus types in individuals with and without skin lesion. J Clin Virol 2006, 36:133-140.
27. Chan S.Y., Ho L., Ong C.K., Chow V., Drescher B., Dürst M., et al. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol 1992, 66:2057-2066.
28. Wong A.K., Chan R.C., Aggarwal N., Singh M.K., Nichols W.S., Bose S. Human papillomavirus genotypes in anal intraepithelial neoplasia and anal carcinoma as detected in tissue biopsies. Mod Pathol 2010, 23:144-150.
29. Daling J.R., Madeleine M.M., Johnson L.G., Schwartz S.M., Shera K.A., Wurscher M.A., et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004, 101:270-280.
30. Coutlée F., Ratnam S., Ramanakumar A.V., Insinga R.R., Bentley J., Escott N., et al. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. J Med Virol 2011, 83:1034-1041.
31. Tricco A.C., Ng C.H., Gilca V., Anonychuk A., Pham B., Berliner S. Canadian oncogenic human papillomavirus cervical infection prevalence: systematic review and meta-analysis. BMC Infect Dis 2011, 11:235.
32. Insinga R.P., Liaw K.L., Johnson L.G., Madeleine M.M. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev 2008, 17:1611-1622.
33. Higgins G.D., Uzelin D.M., Phillips G.E., Pieterse A.S., Burrell C.J. Differing characteristics of human papillomavirus RNA-positive and RNA-negative anal carcinomas. Cancer 1991, 68:561-567.
34. Koulos J., Symmans F., Chumas J., Nuovo G. Human papillomavirus detection in adenocarcinoma of the anus. Mod Pathol 1991, 4:58-61.
35. Davies P., Kornegay J., Iftner T. Current methods of testing for human papillomavirus. Best Pract Res Clin Obstet Gynaecol 2001, 15:677-700.
36. Frisch M., Glimelius B., van den Brule A.J., Wohlfahrt J., Meijer C.J., Walboomers J.M., et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997, 337:1350-1358.
37. Frisch M., Fenger C., van den Brule A.J., Sørensen P., Meijer C.J., Walboomers J.M., et al. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res 1999, 59:753-757.
38. Hernandez B.Y., McDuffie K., Zhu X., Wilkens L.R., Killeen J., Kessel B., et al. Anal human papillomavirus infection in women and its relationship with cervical infection. Cancer Epidemiol Biomarkers Prev 2005, 14:2550-2556.
39. Varnai A.D., Bollmann M., Griefingholt H., Speich N., Schmitt C., Bollmann R., et al. HPV in anal squamous cell carcinoma and anal intraepithelial neoplasia (AIN). Impact of HPV analysis of anal lesions on diagnosis and prognosis. Int J Colorectal Dis 2006, 21:135-142.
40. Daling J.R., Weiss N.S., Hislop T.G., Maden C., Coates R.J., Sherman K.J., et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 1987, 317:973-977.
41. Clifford G.M., Smith J.S., Plummer M., Munoz N., Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003, 88:63-73.
42. Machalek D.A., Poynten M., Jin F., Fairley C.K., Farnsworth A., Garland S.M., et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012, 13:487-500.